The Center for Psychedelic Psychotherapy and Trauma Research in the Department of Psychiatry at Mount Sinai today announced a $2.1 million charitable contribution by the Steven & Alexandra Cohen Foundation.
Kalmon D. Post, MD, Surgical Co-Director of the Pituitary Care and Research Center, and Chair Emeritus of the Department of Neurosurgery, the Faculty Practice Associates, and The Medical Board at Mount Sinai, has been named president-elect of The Pituitary Society, effective Thursday, July 1
Mount Sinai researchers have developed a therapeutic agent that shows high effectiveness in vitro at disrupting a biological pathway that helps cancer survive, according to a paper published in Cancer Discovery, a journal of the American Association for Cancer Research, in July.
Department of Rehabilitation and Human Performance prepares athletes for Tokyo Olympic Games
Mount Sinai researchers have uncovered the complex cellular mechanisms of Ebola virus, which could help explain its severe toll on humans and identify potential pathways to treatment and prevention. In a study published in mBio, the team reported how a protein of the Ebola virus, VP24, interacts with the double-layered membrane of the cell nucleus (known as the nuclear envelope), leading to significant damage to cells along with virus replication and the propagation of disease.
Robotic prostate surgery pioneer Mani Menon, MD, is joining Mount Sinai and will serve as Chief of Strategy and Innovation in the Department of Urology for the Mount Sinai Health System. He will also serve as a Professor of Urology, Director of Education and Director of the Precision Prostatectomy Program in the Department of Urology at Icahn Mount Sinai and Center of Excellence for Prostate Cancer at The Tisch Cancer Institute.
Reflections on the pandemic, developing innovative solutions to address inequities in health and medicine, and the use of psychedelic drugs to help treat psychiatric disorders are among the topics presented at Aspen Ideas Health and the Aspen Ideas Festival from June 27-July 1, 2021, in Aspen, Colorado. Presented by the Aspen Institute and sponsored by the Mount Sinai Health System, the festival is a unique forum for the exchange of ideas.
Repetitive overhead throwing is a risk factor for shoulder injuries in collegiate baseball players, often leading to rotator cuff and biceps tendon injuries.
Only center in the world with this combination of distinctions
Cardiologist will partner with organization to create awareness for congenital heart disease to improve community health
Immune cells that normally repair tissues in the body can be fooled by tumors when cancer starts forming in the lungs and instead help the tumor become invasive, according to a surprising discovery reported by Mount Sinai scientists in Nature in June.
Campaign showcases the people and innovators who are relentlessly advancing medicine and health
The Mount Sinai Hospital is ranked No. 1 in the New York City metropolitan area and No. 4 globally among the most technologically advanced health care institutions on Newsweek’s list of “The World’s Best Smart Hospitals 2021.”
Elementa Labs will connect health care startup companies with Mount Sinai’s vast network of research and clinical experts to advance groundbreaking health care innovations.
Mount Sinai Health System has recruited an internationally recognized expert in the management of breast cancer and HIV-associated malignancies, Joseph A. Sparano, MD, FACP, as Chief of Hematology and Medical Oncology and Deputy Director of The Tisch Cancer Institute (TCI). Dr. Sparano will also hold the Ezra M. Greenspan, MD Professorship in Clinical Cancer Therapeutics at the Icahn School of Medicine at Mount Sinai and will oversee the expansion of clinical and research capacities of the Division and TCI.
Two of Mount Sinai’s top doctors will be honored with prestigious awards at the American Heart Association’s New York City Heart and Stroke Ball, taking place virtually on Wednesday, June 9.
Frequent caffeine intake could more than triple risk of glaucoma for those genetically predisposed to higher eye pressure
MEDIA ADVISORY Senior Author: Ash Tewari, MBBS, MCh, Professor and System Chairman of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai and Director of the Center of Excellence for Prostate Cancer…
An emotion regulation strategy known as cognitive reappraisal helped reduce the typically heightened and habitual attention to drug-related cues and contexts in cocaine-addicted individuals, a study by Mount Sinai researchers has found.
Expanded program will be available to NYC schools and other organizations
EMBARGOED UNTIL MAY 24 2:00PM EST (New York, NY – May 24, 2021) – Having excess pericardial fat—fat around the heart—increases the risk of developing heart failure, especially in women, according to new Mount Sinai research. Women with high amounts…
William Whang, MD, Associate Professor of Medicine (Cardiology), and Gilbert Tang, MD, MSc, MBA, Associate Professor of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai, are receiving the 2021 Simon Dack Awards for their exceptional contributions to the Journal of the American College of Cardiology (JACC).
Study Has Implications for Preventive Measures to Slow Spread of Virus
The investigational drug evinacumab reduced triglycerides in patients with severe hypertriglyceridemia (sHTG) and a history of hospitalizations for acute pancreatitis in a phase 2 global study led by Mount Sinai
(New York, NY – May 10, 2021)- Ophthalmologists at New York Eye and Ear Infirmary of Mount Sinai have created a new technique to evaluate patients with sickle cell retinopathy and assess the disease before it progresses and leads to…
Virologist Gustavo Palacios, PhD, is joining the Icahn School of Medicine at Mount Sinai from the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), where he led the application and development of molecular epidemiology to advance the field of biopreparedness. Dr. Palacios will strengthen existing research collaborations between Icahn Mount Sinai and the United States Army-Department of Defense (DoD), laying a foundation for joint research initiatives to protect national and global public health.
Recognizing that burnout and stress have a negative impact on the personal and professional lives of faculty, staff, and trainees, as well as the quality of care that patients receive, the Mount Sinai Department of Surgery has launched the Stress Intervention Tools (SIT) program to help surgeons work through their emotions, reduce their anxiety, and manage crises.
In honor of Nurses Week, Thursday, May 6, through Wednesday, May 12, Mount Sinai Health System will host several celebratory and commemorative events to celebrate the professionalism, innovation, and resilience of nurses. The events will highlight and showcase the great work of Mount Sinai nurses during this pandemic and beyond, underscoring the importance and prominence of their role in health care.
Oula, a modern maternity center combining the best of obstetrics and midwifery care, today announced its partnership with Mount Sinai West, one of New York’s well-respected hospitals, located on the west side of Manhattan. Through this partnership, Oula patients — who receive prenatal, birth, and postpartum care via the company’s collaborative medical team, Brooklyn clinic, and remote care platform — will now be able to deliver their babies at Mount Sinai. They will receive full access to hospital resources and specialists they may need, all while remaining under the care of Oula’s medical team for non-surgical births.
A combination of remdesivir, a drug currently approved in the United States for treating COVID-19 patients, and repurposed drugs for hepatitis C virus (HCV) was 10 times more effective at inhibiting SARS-CoV-2, the virus that causes COVID-19.
With highly trained specialists skilled in caring for different types of melanoma, patients at the Waldman Melanoma and Skin Center will have access to the newest diagnostics and therapies such as Canfield Vectra180 – a 3D whole body imaging system that captures nearly the entire skin surface in macro quality resolution, and will be able to capture early skin cancer lesions; Nevisense—a safe diagnostic support tool utilizing Electrical Impedence Spectroscopy (EIS) which is applied as a harmless electrical signal to the skin; Vivascope 1500—a non-invasive confocal imaging system which offers a non-invasive way to image the skin to the superficial collagen layers; and innovative technologies which non-invasively collects skin cells through adhesive patches rather than a scalpel to diagnose atypical pigmented lesions (or moles) at high risk for melanoma.
Mount Sinai Researchers Find That Tranexamic Acid, a Blood Clotting Drug Commonly Used for Orthopedic Surgeries, Does Not Increase Complications for High-Risk Patients
The complex patterns of genetic ancestry uncovered from genomic data in health care systems can provide valuable insights into both genetic and environmental factors underlying many common and rare diseases, according to a team of Mount Sinai researchers.
Historic case launches Mount Sinai’s Tracheal Transplant Program for treating patients worldwide, including those with severe intubation damage after COVID-19
MEDIA ADVISORY – UNDER EMBARGO UNTIL Monday, April 5 at 11:00 AM EST Journal Name: Nature Methods Title of the Article: Discovering multiple types of DNA methylation from individual bacteria and microbiome using nanopore sequencing Corresponding Author: Gang Fang, PhD…
Program, an official partner of the New York State Excelsior Pass program, offers fast and accurate testing
MEDIA ADVISORY FOR IMMEDIATE RELEASE: Proceedings of the National Academy of Sciences of the United States (PNAS) Published Online on March 30, 2021 Mount Sinai Researchers Find “Removal of AKAP11 protein by autophagy as a key to fuel mitochondrial metabolism and…
New study identifies a novel approach for tailored treatment that could be more effective for patients with the chronic disease
Mount Sinai researchers have found that a widely available and inexpensive drug targeting inflammatory genes has reduced morbidity and mortality in mice infected with SARS-CoV-2, the virus that causes COVID-19.
Immunotherapy is not only significantly less effective in liver cancer patients who previously had a liver disease called non-alcoholic steatohepatitis (NASH), but actually appears to fuel tumor growth, according to a Mount Sinai study published in Nature in March. NASH affects as many as 40 million people worldwide and is associated with obesity and diabetes.
An epigenetic modification that occurs in a major cell type in the brain’s reward circuitry controls how stress early in life increases susceptibility to additional stress in adulthood, researchers at the Icahn School of Medicine at Mount Sinai have learned.
A single shot of one of the currently authorized COVID-19 vaccines may be sufficient to provide immunity to individuals who have previously been infected by the virus, thus eliminating the need for a second dose and helping to stretch severely limited vaccine supplies, a study from Mount Sinai has found
Mount Sinai Health System announced today that Kantaro Biosciences, LLC, a joint venture with RenalytixAI, has been named to Fast Company’s prestigious annual list of the “World’s Most Innovative Companies” for 2021 and ranked first in the Joint Ventures category.
MEDIA ADVISORY – FOR IMMEDIATE RELEASE Published March 5, 2021 in Science Advances Mount Sinai Researchers find a new way to prevent attention deficits associated with Fragile X, a leading genetic cause of autism, in an animal model. Corresponding Author: Hirofumi…
Hospital also Ranked #1 Regionally in New York City and #7 in the U.S.
Overweight children who were exposed to lead in utero and during their first weeks of life have the potential for poorer kidney function in adulthood, according to an Icahn School of Medicine at Mount Sinai study published in Environment International in March.
Researchers from the Icahn School of Medicine at Mount Sinai have identified a drug that works against depression by a completely different mechanism than existing treatments.
Early detection could reduce the number of African Americans dying from liver cancer, but current screening guidelines may not find cancer soon enough in this community, according to a study published in Cancer in February.
Mount Sinai researchers have identified a neural pathway through which the brain detects errors and guides subsequent behavioral improvement.
Mount Sinai researchers have discovered that Polycomb complexes, groups of proteins that maintain gene expression patterns, are essential for proper skin development, according to a paper published in Genes & Development on February 18.